Newsbenzinga
Novartis, Antares Partner To Pursue Undruggable Cancer Targets In $1.9 Billion Deal
· Published
Article summary
Antares inks Novartis collaboration worth up to $1.9 billion to develop therapies targeting hard-to-treat cancers.
An excerpt from the original article.
Comments —
Loading comments…